Stay updated on KN035 Anti-PD-L1 Clinical Trial
Sign up to get notified when there's something new on the KN035 Anti-PD-L1 Clinical Trial page.

Latest updates to the KN035 Anti-PD-L1 Clinical Trial page
- Check4 days agoChange Detected- Added a consolidated Locations section listing Indiana and Texas locations; removed Indiana Locations and Texas Locations subsections (site structure updated). - Revision updated to v3.3.3.SummaryDifference0.4%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange Detected- The page footer now displays Revision: v3.3.2, replacing Revision: v3.3.1.SummaryDifference0.1%

- Check32 days agoChange DetectedThe Publications section now clarifies that PubMed-derived publications are automatically filled and may not be about the study, and the revision is updated to v3.3.1; the previous PubMed-based wording has been removed (v3.2.0).SummaryDifference0.1%

- Check39 days agoChange DetectedRemoved a generic government funding/operating status notice from the page without altering study details, eligibility, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check53 days agoChange DetectedThe new screenshot shows minor formatting and layout adjustments to the Study Details page, with no changes to core study information (eligibility, endpoints, or locations). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check82 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference3%

Stay in the know with updates to KN035 Anti-PD-L1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KN035 Anti-PD-L1 Clinical Trial page.